Universal Health Services Beheer
Beheer criteriumcontroles 3/4
De CEO Universal Health Services is Marc Miller, benoemd in May2009, heeft een ambtstermijn van 15.5 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 14.41M, bestaande uit 9.4% salaris en 90.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.08% van de aandelen van het bedrijf, ter waarde $ 141.47M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.2 jaar en 6.8 jaar.
Belangrijke informatie
Marc Miller
Algemeen directeur
US$14.4m
Totale compensatie
| Percentage CEO-salaris | 9.4% |
| Dienstverband CEO | 15.5yrs |
| Eigendom CEO | 1.1% |
| Management gemiddelde ambtstermijn | 5.2yrs |
| Gemiddelde ambtstermijn bestuur | 6.8yrs |
Recente managementupdates
Recent updates
Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Nov 10
Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Sep 26Universal Health Services: Stock Has Lots Of Upside Runway
Sep 17Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Aug 10We Think Universal Health Services (NYSE:UHS) Can Stay On Top Of Its Debt
Jul 26Universal Health Services: An Underpriced Healthy Business
Jul 04Is Now The Time To Look At Buying Universal Health Services, Inc. (NYSE:UHS)?
Jun 25Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Jun 10This Is Why Universal Health Services, Inc.'s (NYSE:UHS) CEO Compensation Looks Appropriate
May 09Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 26Market Cool On Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Apr 17Universal Health Services, Inc. (NYSE:UHS) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 01Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Feb 20Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends
Feb 05With Universal Health Services, Inc. (NYSE:UHS) It Looks Like You'll Get What You Pay For
Jan 09Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 48% Undervaluation?
Dec 13What Does Universal Health Services, Inc.'s (NYSE:UHS) Share Price Indicate?
Nov 02Capital Allocation Trends At Universal Health Services (NYSE:UHS) Aren't Ideal
Oct 15Universal Health Services (NYSE:UHS) Takes On Some Risk With Its Use Of Debt
Sep 28Universal Health Services: Seeking A Cure For Flat Performance
Sep 11Is Universal Health Services, Inc. (NYSE:UHS) Potentially Undervalued?
Jul 23Universal Health Services: Business Is On The Mend
Jul 12Returns On Capital Signal Tricky Times Ahead For Universal Health Services (NYSE:UHS)
Jul 10Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Jun 26Calculating The Fair Value Of Universal Health Services, Inc. (NYSE:UHS)
May 28Should You Think About Buying Universal Health Services, Inc. (NYSE:UHS) Now?
Apr 23Universal Health Services (NYSE:UHS) Could Be Struggling To Allocate Capital
Apr 07Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Mar 23Universal Health Services Q4 2022 Earnings Preview
Feb 24Is Universal Health Services, Inc. (NYSE:UHS) Trading At A 31% Discount?
Feb 14Universal Health: Retain Buy As Systematic Defensive Overlay
Feb 04Universal Health Services declares $0.20 dividend
Jan 18Universal Health Services (NYSE:UHS) Will Be Hoping To Turn Its Returns On Capital Around
Jan 05Universal Health Services upgraded at Wells Fargo on improving operating environment
Jan 03Is It Too Late To Consider Buying Universal Health Services, Inc. (NYSE:UHS)?
Dec 21Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Dec 08Universal Health Services: Attractive Even In Light Of Cost Concerns
Nov 14Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 50% Undervaluation?
Nov 10Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$1b |
| Jun 30 2024 | n/a | n/a | US$934m |
| Mar 31 2024 | n/a | n/a | US$816m |
| Dec 31 2023 | US$14m | US$1m | US$717m |
| Sep 30 2023 | n/a | n/a | US$676m |
| Jun 30 2023 | n/a | n/a | US$692m |
| Mar 31 2023 | n/a | n/a | US$684m |
| Dec 31 2022 | US$11m | US$1m | US$675m |
| Sep 30 2022 | n/a | n/a | US$739m |
| Jun 30 2022 | n/a | n/a | US$774m |
| Mar 31 2022 | n/a | n/a | US$935m |
| Dec 31 2021 | US$14m | US$1m | US$990m |
| Sep 30 2021 | n/a | n/a | US$1b |
| Jun 30 2021 | n/a | n/a | US$1b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$2m | US$823k | US$941m |
| Sep 30 2020 | n/a | n/a | US$878m |
| Jun 30 2020 | n/a | n/a | US$734m |
| Mar 31 2020 | n/a | n/a | US$721m |
| Dec 31 2019 | US$4m | US$825k | US$813m |
| Sep 30 2019 | n/a | n/a | US$726m |
| Jun 30 2019 | n/a | n/a | US$801m |
| Mar 31 2019 | n/a | n/a | US$789m |
| Dec 31 2018 | US$4m | US$786k | US$779m |
| Sep 30 2018 | n/a | n/a | US$840m |
| Jun 30 2018 | n/a | n/a | US$810m |
| Mar 31 2018 | n/a | n/a | US$770m |
| Dec 31 2017 | US$4m | US$752k | US$752m |
Compensatie versus markt: De totale vergoeding ($USD 14.41M ) Marc } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.66M ).
Compensatie versus inkomsten: De vergoeding van Marc is het afgelopen jaar met meer dan 20% gestegen.
CEO
Marc Miller (53 yo)
15.5yrs
Tenure
US$14,407,937
Compensatie
Mr. Marc D. Miller has been the President of Universal Health Services, Inc. since May 2009 and also serves as its Chief Executive Officer since January 1, 2021. He has been a Director of Universal Health...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder & Executive Chairman of the Board | 46.8yrs | US$8.37m | 11.71% $ 1.5b | |
| CEO, President & Director | 15.5yrs | US$14.41m | 1.08% $ 141.5m | |
| Executive VP | 25.2yrs | US$4.65m | 0.39% $ 51.5m | |
| Executive VP & President of Behavioral Health Division | 5.2yrs | US$4.05m | 0.00075% $ 97.9k | |
| Executive VP & President of Acute Care Division | 1.9yrs | US$5.47m | 0% $ 0 | |
| Senior VP & General Counsel | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Corporate Development | 7.3yrs | geen gegevens | geen gegevens | |
| Senior VP of Human Resources & Corporate Officer | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of Strategic Services | 7.7yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Finance - Acute Care Division | 4.3yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Finance - Behavioral Health Division | 4.3yrs | geen gegevens | geen gegevens | |
| Senior VP & Controller | no data | geen gegevens | geen gegevens |
5.2yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van UHS is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.2 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder & Executive Chairman of the Board | 46.8yrs | US$8.37m | 11.71% $ 1.5b | |
| CEO, President & Director | 18.5yrs | US$14.41m | 1.08% $ 141.5m | |
| Independent Director | 6.7yrs | US$353.83k | 0.0060% $ 782.1k | |
| Director | 6.8yrs | US$301.33k | 0.0096% $ 1.3m | |
| Lead Independent Director | 11.6yrs | US$344.47k | 0.0081% $ 1.1m | |
| Independent Director | 4.7yrs | US$330.08k | 0.0048% $ 626.7k | |
| Independent Director | 2.2yrs | US$327.07k | 0.0014% $ 176.3k |
6.8yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van UHS wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.8 jaar).